Time
|
Duration
|
Type
|
Presenting person
|
Title
|
May 15th, Monday |
|
| 09:00 |
|
Opening lecture |
Teresa Paszkowska-Reymer |
CAN A QUEST FOR A NEW DRUG OF POLISH ORIGIN BE SUCCESSFUL? |
| 09:45 |
00:45:00 |
Invited Oral |
Jan Lubiński |
THE LATEST ADVANCES IN CLINICAL GENETICS OF BREAST CANCER. |
| 10:50 |
00:20:00 |
Oral |
Andrzej J. Bojarski |
NEW DUAL 5-HT7/5-HT1A LIGANDS WITH ANTIDEPRESSANT AND ANXIOLYTIC-LIKE ACTIVITY |
| 11:10 |
00:20:00 |
Oral |
Ryszard Andruszkiewicz |
NOVEL ANITIEPILEPTIC DRUG - DISCOVERY STORY AND PERSONAL REMARKS |
| 11:30 |
00:20:00 |
Oral |
Lech Kozerski |
NMR INVESTIGATIONS OF HUMAN INSULIN AGGREGATION AND STRUCTURE |
| 11:50 |
00:20:00 |
Oral |
Desmond O' Grady |
AUTOMATED DESIGN OF ROBUST BATCH COOLING CRYSTALLIZATION USING REAL TIME ANALYTICS LASENTEC FBRM AND ReactIR |
| 12:10 |
00:20:00 |
Oral |
Katarzyna Kieć-Kononowicz |
DESIGN AND SYNTHESIS OF HAPTEN TO GENERATE CATALYTIC ANTIBODIES THAT REDUCE PENTOXIFYLLINE |
| 12:30 |
00:20:00 |
Oral |
Agnieszka Bartoszek |
DIETARY INTERVENTION WITH RED BEET JUICE DURING CANCER CHEMOTHERAPY WITH DOXORUBICIN AS MEANS OF COMBATING TOXIC SIDE EFFECTS RESULTING FROM OXIDATIVE STRESS |
| 15:00 |
00:45:00 |
Invited Oral |
Wanda Baer-Dubowska |
CANCER CHEMOPREVENTIVE AGENTS - DRUGS FOR THE 21st CENTURY ? |
| 15:45 |
00:20:00 |
Oral |
Michał Fedoryński |
LARGE SCALE LABORATORY SYNTHESIS OF 1-(4-CHLOROPHENYL)-1-CYANOCYCLO- BUTANE - A SIBUTRAMINE PRECURSOR |
| 16:05 |
00:20:00 |
Oral |
Zbigniew J. Kamiński |
AN APPLICATION OF THE ARRAY OF LIPIDATED OLIGOPEPTIDES RESEMBLING ARTIFICIAL RECEPTORS FOR MOLECULAR RECOGNITION. THE STUDIES ON THE LIPOPHLILICITY OF SOME PIPERAZINES |
| 16:45 |
00:45:00 |
Invited Oral |
Waldemar Priebe |
THE DISCOVERY AND DEVELOPMENT OF BLOOD-BRAIN BARRIER (BBB) PENETRATING ANTHRACYCLINES FOR THE TREATMENT OF BRAIN TUMORS |
| 17:30 |
00:20:00 |
Oral |
Ewa Augustynowicz-Kopeć |
THE IMPORTANCE OF THE TYPE OF ISONIAZID ACETYLATION IN MONITORING OF TUBERCULOSIS TREATMENT. |
| 17:50 |
00:20:00 |
Oral |
Jadwiga Handzlik |
SEARCHING FOR OPTIMAL METHOD FOR SOLUBILITY PREDICTION AMONG BIOLOGICALLY ACTIVE PHENYLPIPERAZINE DERIVATIVES OF PHENYTOIN |
May 16th, Tuesday |
|
| 08:30 |
00:45:00 |
Invited Oral |
Ryszard S. Oliński |
DOES OXIDATIVE DAMAGE TO DNA AND ANTIOXIDANT STATUS HAVE CLINICAL SIGNIFICANCE? |
| 09:15 |
00:45:00 |
Invited Oral |
Władysław Lasoń |
NEW PERSPECTIVES ON THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| 10:00 |
00:20:00 |
Oral |
Zofia Mazerska |
METABOLIC TRANSFORMATIONS OF ANTITUMOR AGENTS WITH CYTOCHROME P-450 ISOENZYMES. |
| 10:20 |
00:20:00 |
Oral |
Dariusz Matosiuk |
STERICAL PREREQUISITES FOR PARTIAL ANTAGONISTS OF GLUTAMINERGIC GLUR5/6 RECEPTORS |
| 11:00 |
00:20:00 |
Oral |
Grzegorz Węgrzyn |
GENE EXPRESSION-TARGETED ISOFLAVONE THERAPY FOR MUCOPOLYSACCHARIDOSES |
| 11:20 |
00:20:00 |
Oral |
Anna Wardowska |
THE BIOLOGICAL ACTIVITY OF NEW TUFTSIN DERIVATIVES - INDUCTION OF PHAGOCYTOSIS. |
| 11:40 |
00:20:00 |
Oral |
Piotr Polcyn |
NEW CORES FOR THE SYNTHESIS OF NEW GENERATION OF DENDRIMERIC PEPTIDES |
| 12:00 |
00:20:00 |
Oral |
Barbara Szechner |
NEW SYNTHESIS OF REPAGLINIDE |
| 14:30 |
00:45:00 |
Invited Oral |
Jerzy Ostrowski |
STRENGTHS AND LIMITATIONS OF INTEGRATIVE GENOMICS EXEMPLIFIED BY STUDIES OF BARRETT'S ESOPHAGUS |
| 15:15 |
00:20:00 |
Oral |
Marek T. Konieczny |
CLICK CHEMISTRY? WE LIKE IT |
| 15:35 |
00:20:00 |
Oral |
Magdalena Jasińska |
THE INFLUENCE OF SIMVASTATIN IN HIGH DOSE AND DILTIAZEM ON MYOCARDIUM IN RABBITS |
| 16:15 |
00:45:00 |
Invited Oral |
Stanislaw Słomkowski |
NANOPARTICLES FROM POLYESTER-CONTAINING BLOCK COPOLYMERS AS CARRIERS OF BIOACTIVE COMPOUNDS |
| 17:00 |
00:20:00 |
Oral |
Sławomir Milewski |
ANTIFUNGAL DRUGS AND MULTIDRUG RESISTANCE - AN OPEN PROBLEM |
| 17:20 |
00:20:00 |
Oral |
Maria Kraj |
INCIDENCE OF JAW OSTEONECROSIS IN MYELOMA PATIENTS TREATED WITH BISPHOSPHONATES |
May 17th, Wednesday |
|
| 08:30 |
00:45:00 |
Invited Oral |
Renata Jachowicz |
RECENT TRENDS IN ORAL DRUG IMPROVEMENT |
| 09:15 |
00:45:00 |
Invited Oral |
Jacek Gawroński |
ASYMMETRIC SYNTHESES AND TRANSFORMATIONS - TOOLS FOR CHIRALITY MULTIPLICATION IN DRUG SYNTHESIS |
| 10:20 |
00:20:00 |
Oral |
Krystyna Gryz |
EUROPEAN CRITERIA FOR QUALITY ASSESSMENT OF CHEMICAL AND BIOLOGICAL MEDICINAL PRODUCTS DURING THE REGISTRATION PROCESS |
| 11:00 |
00:45:00 |
Invited Oral |
Piotr T. Siedlecki |
FACTS AND MYTHS CONCERNING CLINICAL TRIALS OF ONCOLOGICAL DRUGS |
| 14:30 |
00:45:00 |
Oral |
Marcin Grabowski |
PROGRESS IN CARDIOVASCULAR DISEASES TREATMENT |
| 15:15 |
00:20:00 |
Oral |
Jolanta Obniska |
ANTICONVULSANT PROPERTIES AND 5-HT1A, 5-HT2A RECEPTOR AFFINITY OF NEW N-[(4-ARYLPIPERAZIN-1-YL)-ALKYL] - 2 - AZASPIRO[4.4]NONANE- AND [4.5]DECANE-1,3-DIONES |
| 15:35 |
00:20:00 |
Oral |
Katarzyna Jelonek |
LONG-TERM CYCLOSPORINE A (CyA) AND SIROLIMUS RELEASE FROM BIODEGRADABLE MATRICES AS A RESULT OF OPTIMAL ADJUSTMENT OF COPOLYMER CHAIN MICROSTRUCTURE |
| 15:55 |
00:20:00 |
Oral |
Krzysztof Jóźwiak |
MOLECULAR INTERACTIONS BETWEEN NICOTINIC ACETYLCHOLINE RECEPTOR AND ITS LIGANDS - CHROMATOGRAPHIC AND MODELING APPROACHES |
| 16:15 |
00:20:00 |
Oral |
Krzysztof Kurowski |
MODULATION OF TRANSCRIPTIONAL ACTIVITY IN ADIPOSE TISSUE OF db/db MICE AFTER ORAL ADMINISTRATION OF NOVEL POTENTIAL ANTIDIABETIC DRUGS (AD10369, AD10371, AD10797, AD10798 AND AD101025). |
| 16:35 |
00:20:00 |
Oral |
Ewa Leciejewicz-Ziemecka |
PHARMACOPOEIA - SET OF QUALITY REQUIREMENTS FOR MEDICINAL PRODUCTS |
| 16:55 |
00:20:00 |
Oral |
Agnieszka Adamczyk |
NEW 3-ALKENYL DERIVATIVES OF RIFAMYCIN ANTIBIOTICS |
